Self-assembling peptide nanoparticles for vaccine epitope display
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current vaccine technologies face challenges in inducing both strong humoral and cellular immune responses effectively, particularly in displaying T-cell epitopes in a manner that allows for efficient MHC binding and coiled-coil formation within self-assembling peptide nanoparticles (SAPN), which is crucial for effective immunization.
Innovation Solution
The development of self-assembling peptide nanoparticles (SAPN) that incorporate T-cell and B-cell epitopes within coiled-coil oligomerization domains, utilizing specific peptide sequences and linker segments to ensure proper oligomerization and MHC binding, while also incorporating proteasomal cleavage sites for CTL epitopes and promiscuous HTL epitopes to enhance immune response.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If T-cell epitopes are incorporated into coiled-coil oligomerization domains for efficient MHC binding, then cellular immune response is enhanced, but the structural constraints of coiled-coil formation may limit epitope incorporation
Solution Approach 1:
The peptide is divided into distinct functional segments: coiled-coil oligomerization domains (for nanoparticle formation), linker segments (for flexibility and proper spacing), and T-cell epitope sequences (for MHC binding). This segmentation allows each element to perform its specific function without interfering with others, resolving the contradiction between structural constraints and epitope incorporation
Solution Approach 2:
Different regions of the peptide are assigned different properties: the coiled-coil domains provide rigid oligomerization capability, the linker segments provide flexibility and proper spacing, and the epitope regions provide specific MHC binding affinity. This local differentiation allows simultaneous optimization of nanoparticle formation and immune recognition
2Reliability
If B-cell epitopes are displayed repetitively on nanoparticle surface, then humoral immune response is enhanced, but the nanoparticle size and antigen density must be precisely controlled
Solution Approach 1:
The peptide sequence is designed to self-assemble into nanoparticles with defined size and structure through intrinsic coiled-coil oligomerization properties. The self-assembling capability ensures consistent nanoparticle formation without requiring complex external control mechanisms, achieving both high antigen density and controlled size
Solution Approach 2:
The nanoparticle is constructed as a composite of multiple peptide chains organized into ordered oligomeric structures (dimers, trimers, pentamers). This composite architecture provides both the repetitive antigen display needed for strong humoral response and the structural regularity needed for controlled size and stability
3Reliability
If proteasomal cleavage sites are incorporated for CTL epitopes, then cellular immunity is enhanced, but the peptide sequence becomes more complex
Solution Approach 1:
Proteasomal cleavage sites are incorporated at the C-terminus of CTL epitopes in advance, ensuring that intracellular processing and antigen presentation are efficiently initiated. This preliminary inclusion of processing signals simplifies the overall design by integrating multiple functional requirements into a single optimized sequence
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The SAPN effectively induce robust immune responses by repetitive antigen display of B-cell epitopes and efficient presentation of T-cell epitopes, enhancing both humoral and cellular immunity, and can be designed for specific pathogens like malaria and influenza, offering a versatile platform for vaccine development.
Implementation Method 1
nanoparticles of the invention consist of aggregates of a continuous peptidic chain comprising two oligomerization domains connected by a linker segment wherein one or both oligomerization domains is a coiled-coil that incorporates T-cell epitopes and/or B-cell epitopes within its peptide sequence
Data Source
AI summary
Self-assembling peptide nanoparticles (SAPN) incorporating T-cell epitopes and/or B-cell epitopes are described. The nanoparticles of the invention consist of aggregates of a continuous peptidic chain comprising two oligomerization domains connected by a linker segment wherein one or both oligomerization domains incorporate T-cell epitopes and/or B-cell epitopes within their peptide sequence. These nanoparticles are useful as vaccines and adjuvants.